The UK government today published four documents about how Brexit will impact the operations and regulatory status of life sciences companies.
German scientists claim to have developed a way of identifying counterfeit breast implants by using DNA sequences from tomatoes.
Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries.
Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings.
Dusa Pharmaceuticals, a subsidiary of India-based generic drug maker Sun Pharma, has accused dermatology-focused company Biofrontera of misappropriating trade secrets.
A medical technology trade association has warned that the US tariffs recently implemented in response to Chinese IP theft may hinder patient access to life-saving technologies.
Novartis has created a platform called Nerve Live that will tap into its “huge data pool” in order to aid drug development.
Clinical technology company Medidata has bought Shyft Analytics, a cloud data analytics platform, for $195 million.
An Indiana district court did not abuse its discretion in denying attorneys’ fees to medical device company Cook Medical, the US Court of Appeals for the Federal Circuit said yesterday in a precedential decision.
The US International Trade Commission announced yesterday that it will investigate certain blood cholesterol testing systems and strips after receiving a complaint from Polymer Technology System.